Clinical background
Seizures began at age 5, with two anti-seizure medicines tried at adequate doses without sustained control. EEG showed a left temporal focus. A 1.5T MRI was reported as showing no structural abnormality.
Paediatric neurology · United Kingdom
Parents of a 7-year-old with drug-resistant focal seizures requested an independent read of the brain MRI reported as normal, before a planned change of anti-seizure medication.
Seizures began at age 5, with two anti-seizure medicines tried at adequate doses without sustained control. EEG showed a left temporal focus. A 1.5T MRI was reported as showing no structural abnormality.
“Has the imaging been acquired and reported using a protocol suited to identifying subtle epileptogenic lesions in a child with a defined electrographic focus?”
Dates are expressed as intervals rather than calendar dates, and identifying details have been altered, so that the sequence of care can be followed without identifying the patient.
Age 5
Focal seizure with impaired awareness, described as behavioural arrest with oral automatisms lasting around 90 seconds.
Age 5 + 2 months
Interictal epileptiform discharges over the left temporal region.
Age 5 + 3 months
Started and titrated to an adequate maintenance dose; partial response only.
Age 6
Standard paediatric brain protocol reported as showing no structural abnormality.
Age 6 + 5 months
Added after continued seizures; adherence confirmed and levels checked where applicable. Seizure control remained incomplete.
Age 7
Two appropriately chosen and adequately dosed medicines had failed to achieve sustained seizure freedom.
Age 7 + 1 month
Parents uploaded DICOM imaging, EEG reports and clinic letters ahead of a planned third medication change.
Age 7 + 1 month, 5 days
Reviewed jointly by a paediatric neurologist and a neuroradiologist, with a plain-language family section and a separate technical section for the treating team.
Age 7 + 3 months
Treating service arranged repeat MRI using a dedicated epilepsy protocol and made a tertiary referral.
Every item supplied by the patient was indexed before review. Nothing was assessed in isolation from the rest of the record.
Acquisition parameters compared against published epilepsy-protocol recommendations.
Electrographic focus localisation cross-referenced with the imaging coverage.
Reviewed for dose adequacy, adherence and the definition of treatment failure applied.
Used to characterise semiology and frequency over 24 months.
Reviewed for cognitive and behavioural trajectory alongside seizure burden.
Confirmed both medicines had been trialled at adequate maintenance doses.
Every report ends with a prepared question list. The questions are written to be asked of the patient's own clinician — they are prompts for discussion, not recommendations.
Extracts from the signed specialist report, reproduced in the same section order used in every MedReview 365 report.
The family raised the protocol question at their next appointment. The treating team arranged repeat imaging with an epilepsy protocol and a tertiary referral. All clinical decisions remained with the treating service.
This case study is anonymised, published with patient consent and altered where necessary to prevent identification. It describes how one written second opinion was prepared and discussed. It is not a treatment recommendation, not a diagnosis, and not an indication of any expected result in another patient. Always discuss your care with your own treating clinician, and seek emergency care for urgent or deteriorating symptoms.